PATENT CLAIM ANALYSIS

Application Number: 16091674
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "016500"]

Abstract:
The present specification relates to a composition containing a peptide having effects of increasing telomerase activity and extending a telomere, and more specifically, to a composition containing a telomerase-derived peptide, thereby being effective for preventing, alleviating and treating diseases, caused by a decrease in telomerase activity or a reduction in telomere length, and symptoms caused by cell aging or damage. According to one aspect to the present invention, the peptide increases telomerase activity and is effective for extending a telomere, and thus a method for treating diseases induced by an abnormal decrease in telomerase activity and by the length reduction or loss of a telomere and alleviating symptoms caused thereby can be provided.

Claim (Index 24):
The method according to  claim 20 , wherein the pharmaceutical composition is in the form of tablets, pills, soft capsules, hard capsules, granules, powders, solutions, emulsions, injections, drips, lotions, ointments, gels, creams, suspensions, emulsions, suppositories, patches, or sprays.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 2.12069
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15038269', '15303370', '15539396', '15136353', '14400299']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.739962186792952
- 35 USC 102 Novelty (BERT): 0.5136542069973955
- Combined Prediction Score: 0.7173313888133964
- Mean Citation Score: 260.91548
- Max Citation Score: 267.13126
- Similarity Product: 134.85608171911838

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test